Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

The Food and Drug Administration is projecting a more favorable stance toward biotech, emphasizing streamlined processes and accelerated approvals (“FDA Sends a Bullish Signal to Biotech ...

He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. Caribou Biosciences is ...

Cepheid, a large biotechnology company ... or another Bay Area tech company? Contact tech reporter Stephen Council securely at [email protected] or on Signal at 628-204-5452.

His ousting of Peter Marks—a senior official at the Food and Drug Administration and key proponent of faster drug approvals—sent biotech stocks tumbling last month and stoked concerns that the ...

Both companies ... while Signal has several drugs in the pipeline but none producing revenue. “It's a good match for Celgene,” says Caroline Copithorne, biotechnology analyst at Morgan Stanley ...